499
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor: Medical Oncology

Unusual cases of sinonasal malignancies: a letter to the editor on HPV-positive sinonasal squamous cell carcinomas

, , ORCID Icon, & ORCID Icon
Pages 608-613 | Received 10 Feb 2023, Accepted 01 Jun 2023, Published online: 19 Jun 2023

References

  • Kılıç S, Kılıç SS, Kim ES, et al. Significance of human papillomavirus positivity in sinonasal squamous cell carcinoma. Int Forum Allergy Rhinol. 2017;7(10):980–989. doi: 10.1002/alr.21996.
  • But-Hadzic J, Jenko K, Poljak M, et al. Sinonasal inverted papilloma associated with squamous cell carcinoma. Radiol Oncol. 2011;45(4):267–272. doi: 10.2478/v10019-011-0033-4.
  • Bishop JA, Ma X-J, Wang H, et al. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol. 2012;36(12):1874–1882. doi: 10.1097/PAS.0b013e318265fb2b.
  • Tendron A, Classe M, Casiraghi O, et al. Prognostic analysis of HPV status in sinonasal squamous cell carcinoma. Cancers. 2022;14(8):1874. doi: 10.3390/cancers14081874.
  • Sjöstedt S, von Buchwald C, Agander TK, et al. Impact of human papillomavirus in sinonasal cancer—a systematic review. Acta Oncol. 2021;60(9):1175–1191. doi: 10.1080/0284186X.2021.195092.
  • Garset-Zamani M, Carlander AF, Jakobsen KK, et al. Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer. Int J Cancer. 2022;150(7):1174–1183. doi: 10.1002/ijc.33893.
  • Nishikawa D, Sasaki E, Suzuki H, et al. Treatment outcome and pattern of recurrence of sinonasal squamous cell carcinoma with EGFR-mutation and human papillomavirus. J Craniomaxillofac Surg. 2021;49(6):494–500. doi: 10.1016/j.jcms.2021.02.016.
  • Cabal VN, Menéndez M, Vivanco B, et al. EGFR mutation and HPV infection in sinonasal inverted papilloma and squamous cell carcinoma. Rhin. 2020;58(4):368–376. doi: 10.4193/Rhin19.371.
  • Cohen E, Coviello C, Menaker S, et al. P16 and human papillomavirus in sinonasal squamous cell carcinoma. Head Neck. 2020;42(8):2021–2029. doi: 10.1002/hed.26134.
  • Doescher J, Piontek G, Wirth M, et al. Epstein–Barr virus infection is strictly associated with the metastatic spread of sinonasal squamous-cell carcinomas. Oral Oncol. 2015;51(10):929–934. doi: 10.1016/j.oraloncology.2015.07.008.
  • Larque AB, Hakim S, Ordi J, et al. High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomas. Mod Pathol. 2014;27(3):343–351. doi: 10.1038/modpathol.2013.155.
  • Hongo T, Yamamoto H, Jiromaru R, et al. PD-L1 expression, tumor-infiltrating lymphocytes, mismatch repair deficiency, EGFR alteration and HPV infection in sinonasal squamous cell carcinoma. Mod Pathol. 2021;34(11):1966–1978. doi: 10.1038/s41379-021-00868-w.
  • Li H, Torabi SJ, Yarbrough WG, et al. Association of human papillomavirus status at head and neck carcinoma subsites with overall survival. JAMA Otolaryngol Head Neck Surg. 2018;144(6):519–525. doi: 10.1001/jamaoto.2018.0395.
  • Hu C, Quan H, Yan L, et al. Prevalence of human papillomavirus in sinonasal squamous cell carcinoma with and without association of inverted papilloma in Eastern China. Infect Agent Cancer. 2020;15:36. doi: 10.1186/s13027-020-00298-4.
  • Laco J, Sieglová K, Vošmiková H, et al. The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis. Virchows Arch. 2015;467(4):405–415. doi: 10.1007/s00428-015-1812-x.
  • Jo VY, Mills SE, Stoler MH, et al. Papillary squamous cell carcinoma of the head and neck: frequent association with human papillomavirus infection and invasive carcinoma. Am J Surg Pathol. 2009;33(11):1720–1724. doi: 10.1097/PAS.0b013e3181b6d8e6.
  • Kim Y, Joo YH, Kim MS, et al. Prevalence of high-risk human papillomavirus and its genotype distribution in head and neck squamous cell carcinomas. J Pathol Transl Med. 2020;54(5):411–418. doi: 10.4132/jptm.2020.06.22.
  • Jiromaru R. HPV-related sinonasal carcinoma clinicopathologic features, diagnostic utility of p16 and rb immunohistochemistry, and EGFR copy number alteration. Am J Surg Pathol. 2020;44(3):305–315. doi: 10.1097/PAS.0000000000001410.
  • Oliver JR, Lieberman SM, Tam MM, et al. Human papillomavirus and survival of patients with sinonasal squamous cell carcinoma. Cancer. 2020;126(7):1413–1423. doi: 10.1002/cncr.32679.
  • Schlussel Markovic E, Marqueen KE, Sindhu KK, et al. The prognostic significance of human papilloma virus in sinonasal squamous cell carcinoma. Laryngoscope Investig Otolaryngol. 2020;5(6):1070–1078. doi: 10.1002/lio2.468.
  • Hongo T, Yamamoto H, Jiromaru R, et al. Clinicopathologic significance of EGFR. Mutation and 2021;45(1):108–118. doi: 10.1097/PAS.0000000000001566.
  • Svajdler M. Significance of transcriptionally-active high-risk human papillomavirus in sinonasal squamous cell carcinoma: case series and a meta-analysis. Neoplasma. 2020;67(6):1456–1463. doi: 10.4149/neo_2020_200330N332.
  • Al-Qurayshi Z, Smith R, Walsh JE. Sinonasal squamous cell carcinoma presentation and outcome: a national perspective. Ann Otol Rhinol Laryngol. 2020;129(11):1049–1055. doi: 10.1177/0003489420929048.
  • Yamashita Y, Hasegawa M, Deng Z, et al. Human papillomavirus infection and immunohistochemical expression of cell cycle proteins pRb, p53, and p16INK4a in sinonasal diseases. Infect Agents Cancer. 2015;10(1):8. doi: 10.1186/s13027-015-0019-8.
  • Alos L, Moyano S, Nadal A, et al. Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer. 2009;115(12):2701–2709. doi: 10.1002/cncr.24309.
  • Chowdhury N, Alvi S, Kimura K, et al. Outcomes of HPV-related nasal squamous cell carcinoma. Laryngoscope. 2017;127(7):1600–1603. doi: 10.1002/lary.26477.
  • Cheung FMF, Lau TWS, Cheung LKN, et al. Schneiderian papillomas and carcinomas: a retrospective study with special reference to p53 and p16 tumor suppressor gene expression and association with HPV. Ear, Nose Throat J. 2010;89(10):E5–E12. doi: 10.1177/014556131008901002.
  • Bishop JA, Guo TW, Smith DF, et al. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol. 2013;37(2):185–192. doi: 10.1097/PAS.0b013e3182698673.
  • Toustrup K, Lambertsen K, Birke-Sørensen H, et al. Reduction in waiting time for diagnosis and treatment of head and neck cancer – a fast track study. Acta Oncol. 2011;50(5):636–641. doi: 10.3109/0284186X.2010.551139.
  • Lewis JS. Sinonasal squamous cell carcinoma: a review with emphasis on emerging histologic subtypes and the role of human papillomavirus. Head and Neck Pathol. 2016;10(1):60–67. doi: 10.1007/s12105-016-0692-y.
  • Zhang SC, Wei L, Zhou SH, et al. Inability of PET/CT to identify a primary sinonasal inverted papilloma with squamous cell carcinoma in a patient with a submandibular lymph node metastasis: a case report. Oncol Lett. 2015;10(2):749–753. doi: 10.3892/ol.2015.3328.
  • Ahn PH, Mitra N, Alonso-Basanta M, et al. Risk of lymph node metastasis and recommendations for elective nodal treatment in squamous cell carcinoma of the nasal cavity and maxillary sinus: a SEER analysis. Acta Oncol. 2016;55(9-10):1107–1114. doi: 10.1080/0284186X.2016.1216656.
  • Forslund O, Johansson H, Madsen KG, et al. The nasal mucosa contains a large spectrum of human papillomavirus types from the betapapillomavirus and gammapapillomavirus genera. J Infect Dis. 2013;208(8):1335–1341. doi: 10.1093/infdis/jit326.
  • Zur Hausen H. Papillomaviruses in the causation of human cancers – a brief historical account. Virology. 2009;384(2):260–265. doi: 10.1016/j.virol.2008.11.046.
  • Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):60–72. doi: 10.1056/NEJMra1715715.
  • Grønhøj C, Jensen D, Dehlendorff C, et al. Impact of time to treatment initiation in patients with human papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma. Clin Oncol. 2018;30(6):375–381. doi: 10.1016/j.clon.2018.02.025.
  • Carlander ALF, Grønhøj Larsen C, Jensen DH, et al. Continuing rise in oropharyngeal cancer in a high HPV prevalence area: a Danish population-based study from 2011 to 2014. Eur J Cancer. 2017;70:75–82. doi: 10.1016/j.ejca.2016.10.015.
  • Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35. doi: 10.1056/NEJMoa0912217.
  • Syrjänen S, Syrjänen K. HPV in head and neck carcinomas: different HPV profiles in oropharyngeal carcinomas – why? Acta Cytol. 2019;63(2):124–142. doi: 10.1159/000495727.
  • Grønhøj Larsen C, Jensen DH, Fenger Carlander A-L, et al. Novel nomograms for survival and progression in HPV + and HPV- oropharyngeal cancer: a population-based study of 1,542 consecutive patients. Oncotarget. 2016;7(44):71761–71772. doi: 10.18632/oncotarget.12335.
  • Syrjänen K, Syrjänen S. Detection of human papillomavirus in sinonasal carcinoma: systematic review and meta-analysis. Hum Pathol. 2013;44(6):983–991. doi: 10.1016/j.humpath.2012.08.017.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.